Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19

Identification of factors behind the level and duration of persistence of the SARS-CoV-2 antibodies in the blood is assumed to set the direction for studying humoral immunity mechanisms against COVID-19, optimizing the strategy for vaccine use, antibody-based drugs, and epidemiological control of CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolosova, Evgeniia A., Shaprova, Olga N., Shanshin, Daniil V., Nesmeyanova, Valentina S., Merkuleva, Iuliia A., Belenkaya, Svetlana V., Isaeva, Anastasiya A., Nikitin, Artem O., Volosnikova, Ekaterina A., Nikulina, Yuliya A., Nikonorova, Marina A., Shcherbakov, Dmitry N., Elchaninova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322357/
https://www.ncbi.nlm.nih.gov/pubmed/35887818
http://dx.doi.org/10.3390/jcm11144053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322357/
https://www.ncbi.nlm.nih.gov/pubmed/35887818
http://dx.doi.org/10.3390/jcm11144053

Ejemplares similares